Biosensors & Smart Diagnostic Devices
The U.S. biosensors and smart diagnostic devices market is growing with rising demand for continuous health monitoring, rapid testing, and connected diagnostic technologies. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across wearable biosensors, electrochemical sensors, point-of-care platforms, and intelligent diagnostic systems.
Valued at USD 14.80 billion in 2026, the U.S. Biosensors Market is projected to reach USD 25.12 billion by 2032, expanding at a 9.22% CAGR. Growth is fueled by accelerating clinical adoption of wearable continuous glucose monitors, decentralization of rapid point-of-care emergency diagnostics, and breakthroughs in semiconductor-driven electrochemical and photonic biosensing platforms across inpatient and home healthcare settings.
Read Report Details